Article Details

Emergent BioSolutions (NYSE:EBS) Upgraded to Hold at Zacks Investment Research

Retrieved on: 2021-06-22 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Emergent BioSolutions (NYSE:EBS) Upgraded to Hold at Zacks Investment Research. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nyse-ebs-a-buy-or-sell-right-now-2021-06-2-3/

Excerpt

Neo Ivy Capital Management now owns 403 shares of the biopharmaceutical company's stock worth $36,000 after buying an additional 342 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up